Palabras clave
Inmunoterapia
Terapia génica
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Evaluar la efectividad de la inmunoterapia en una amplia gama de neoplasias. Métodos: Estudio cienciométrico utilizando las bases de datos PubMed, Scientific Electronic Library Online (Scielo) y Science Direct. Se siguieron criterios de inclusión que abarcan artículos publicados a nivel nacional e internacional, sin restricción de período de publicación y en estudios clínicos e investigaciones de análisis disponibles de forma gratuita. Para procesar los datos se utilizaron programas como VosViewer, Mendeley y Excel. Resultados: Se incluyeron 32 artículos. Las publicaciones de artículos van desde 1969 hasta 2024 y ofrecen una visión integral de la evolución de la investigación en inmunoterapia durante más de medio siglo. Esto permite a los investigadores trazar el progreso e identificar áreas de crecimiento e interés continuos. Ha habido un aumento notable en la cantidad de investigaciones publicadas en los últimos años, lo que refleja un creciente interés e inversión en el área de la inmunoterapia del cáncer. Conclusión: Los estudios sobre el tema siguen una trayectoria prometedora, con avances significativos y un futuro lleno de potencial. La medicina de precisión, la tecnología de vanguardia y la colaboración internacional están impulsando este campo, convirtiéndolo en una parte esencial de la oncología moderna.
Referencias
AMHIS N, et al. Transforming pancreaticobiliary cancer treatment: Exploring the frontiers of adoptive cell therapy and cancer vaccines. Molecular Therapy: Oncology, 2024, 200825.
ASCIERTO PA, et al. Epithelioid cell-type melanoma as a prognostic factor of poor response to immunological treatment. Annals of Oncology, 2000; 1504.
BANDO H, et al. Novel Immunological Approaches in the Treatment of Locally Advanced Rectal Cancer. Clinical Colorectal Cancer, 2022; 3–9.
BARBIERI C, et al. Effect of surgical treatment on the cellular immune response of gastric cancer patients. Brazilian Journal of Medical and Biological Research, 2003; 339–345.
BARROS L, et al. Immunological-based approaches for cancer therapy. Clinics, 2018; 429.
CHIRIVA-INTERNATI M. Immunological treatment of liver tumors. World Journal of Gastroenterology, 2005; 6571.
CHIRIVA-INTERNATI M, et al. Cancer immunotherapy: avoiding the road to perdition. Journal of Translational Medicine, 2004; 26.
GUO C, et al. Tumor immunological phenotype-derived gene classification predicts prognosis, treatment response, and drug candidates in ovarian cancer. Genes & Diseases, 2024; 101173.
HADILOO K, et al. The new era of immunological treatment, last updated and future consideration of CAR T cell-based drugs. Pharmacological Research, 2024; 107158.
HAWLEY JE, et al. Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer. Cancer Cell, 2023; 1972-19885.
HUNG SI, et al. Personalized neoantigen-based T cell therapy triggers cytotoxic lymphocytes expressing polyclonal TCR against metastatic ovarian cancer. Biomedicine & Pharmacotherapy, 2023; 115928.
JANICZEK M, et al. Immunotherapy as a Promising Treatment for Prostate Cancer: A Systematic Review. Journal of Immunology Research, 2017; 1–6.
KHAN JA e YAQIN S. Dendritic cell therapy with improved outcome in glioma multiforme—A case report. Journal of Zhejiang University SCIENCE B, 2006; 114–117.
KHAN JA e YAQIN S. Successful immunological treatment of gallbladder cancer in India—Case report. Journal of Zhejiang University SCIENCE B, 2006; 719–724.
LIN MH, et al. Immunological evaluation of a novel HLA-A2 restricted phosphopeptide of tumor associated Antigen, TRAP1, on cancer therapy. Vaccine: X, 2019; 100017.
LÓPEZ M, et al. Avances en inmunoterapia celular contra el melanoma maligno. Revista Médica de Chile, 2004.
MATHE G. Approaches to the immunological treatment of cancer in man. BMJ, 1969; 7–10.
MATHE G. Immunological treatment of leukaemias. BMJ, 1970; 487–488.
MOKKAPATI S, et al. Lentiviral interferon: A novel method for gene therapy in bladder cancer. Molecular Therapy - Oncolytics, 2022;141–157.
NAGORSEN D e THIEL E. HLA typing demands for peptide-based anti-cancer vaccine. Cancer Immunology, Immunotherapy, 2008; 1903–1910.
PORTER LH, et al. Left out in the cold: Moving beyond hormonal therapy for the treatment of immunologically cold prostate cancer with CAR T cell immunotherapies. The Journal of Steroid Biochemistry and Molecular Biology, 2024; 106571.
QI L, et al. Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology. Genes & Diseases, 2024; 101155.
RANGEL-SOSA MM, et al. Imunoterapia e terapia genética como novos tratamentos para o câncer. Colombia Médica, 2017; 138–147.
SANDOVAL-VALENCIA RR. Cancer immunotherapy: Role of the immune system in malignant transformation. Revista Médica Del Hospital General de México, 2019.
SCHUTT C, et al. Immunological Treatment Options for Locoregionally Advanced Head and Neck Squamous Cell Carcinoma. International Reviews of Immunology, 2012; 22–42.
SONG J e WU L. Friend or Foe: Prognostic and Immunotherapy Roles of BTLA in Colorectal Cancer. Frontiers in Molecular Biosciences, 2020.
VAN GENUGTEN EAJ, et al. Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy. Frontiers in Oncology, 2022.
WÜRFEL FM, et al. European Patent in Immunoncology: From Immunological Principles of Implantation to Cancer Treatment. International Journal of Molecular Sciences, 2019; 1830.
XIE W, et al. The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells. International Journal of Nanomedicine, 2019; 9377–9393.
YANG Y, et al. Identification and Validation of Efficacy of Immunological Therapy for Lung Cancer From Histopathological Images Based on Deep Learning. Frontiers in Genetics, 2021.
YOUNG MRI. Redirecting the focus of cancer immunotherapy to premalignant conditions. Cancer Letters, 2017; 83–88.
ZENG H, et al. Diagnostic, prognostic, and immunological roles of CDSN in ovarian cancer. Heliyon, 2024, 33357.